Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Struggling with the Silent Killer: An Honest Look at How Demanding Oncology Trials Have Become with Rebecca Setta

Struggling with the Silent Killer: An Honest Look at How Demanding Oncology Trials Have Become with Rebecca Setta

FromConversations in Clinical Trial Readiness


Struggling with the Silent Killer: An Honest Look at How Demanding Oncology Trials Have Become with Rebecca Setta

FromConversations in Clinical Trial Readiness

ratings:
Length:
29 minutes
Released:
Apr 20, 2021
Format:
Podcast episode

Description

Rebecca Setta is an Associate Director at OncoSec whose 13 years of experience in clinical trials have given her the benefit of several different perspectives. Rebecca began her career on the vendor side, and her continuous pursuit of development and higher-level understanding led her to transition to the CRO space in 2015. Her role at OncoSec represents the natural evolution of a career shaped around an inherent desire for growth through further immersion in clinical trials.In Rebecca’s years of experience at the project level, she consistently found building effective teams to be among the most rewarding elements of her work. She now brings that expertise to bear at the department level, where she can act as a mentor, shaping a team to build on her knowledge and experience. Episode HighlightsHow Rebecca helps her team avoid burnout in a grueling fieldThe common characteristics she saw across the sites that adapted best at the start of the pandemicThe crucial change in mindset that she’s encouraged in her CRAsThe COVID-inflicted adaptations she expects to persist post-pandemicWhy it’s important to partner with sitesThe unexpected upside to the pandemic adjustments her sites have madeWhat really impresses her about the industryHow remote work and limited face time can impact morale, and one way she compensates for thatHow the weighty context of oncology research can also translate to motivationWhy she is so excited about the future of the industryResourceshttps://oncosec.comhttps://www.linkedin.com/company/oncosec-medical-inc/https://twitter.com/oncosec
Released:
Apr 20, 2021
Format:
Podcast episode

Titles in the series (12)

Welcome to Conversations in Clinical Trial Readiness, a series featuring life science executives who share their stories and insights related to clinical operations, and clinical trial readiness.